Elevation Oncology Inc. Gains 29.25%

Fri, Jan 12, 2024 at 07:38 PM
Elevation Oncology Inc. Gains 29.25%

Elevation Oncology Inc. (ELEV:NASDAQ) jumped higher at $2.74, representing a gain of 29.2%. On Fri, Jan 12, 2024, ELEV:NASDAQ touched a New 2-Week High of $2.74. The stock appeared on our News Catalysts scanner on Tue, Jan 09, 2024 at 02:07 PM in the 'BIOTECH' category. From Tue, Jan 02, 2024, the stock recorded 62.50% Up Days and 77.78% Green Days

About Elevation Oncology Inc. (ELEV:NASDAQ)

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.